Although gender-based medicine is a relatively recent concept, it is now emerging as an important field of research, supported by the finding that many diseases manifest differently in men and women and therefore, might require a different treatment. Sex-related differences regarding the epidemiology, progression and treatment strategies of certain liver diseases have long been known, but most of the epidemiological and clinical trials still report results only about one sex, with consequent different rate of response and adverse reactions to treatment between men and women in clinical practice. This review reports the data found in the literature concerning the gender-related differences for the most representative hepatic diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.phrs.2017.03.014 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!